Viewing Study NCT01692834


Ignite Creation Date: 2025-12-25 @ 2:36 AM
Ignite Modification Date: 2026-02-05 @ 9:55 AM
Study NCT ID: NCT01692834
Status: COMPLETED
Last Update Posted: 2014-08-01
First Post: 2012-09-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Compare the Bioavailability and Pharmacokinetics of Cyclosporine After Intravenous Administration of NEUROSTAT®, a CREMOPHOR® EL-free Lipid Emulsion, and SANDIMMUNE® Injection (a Suspension of Cyclosporine in CREMOPHOR® EL) in Healthy Volunteers
Sponsor: NeuroVive Pharmaceutical AB
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bioequivalence View
None pharmacokinetics View
None tolerability View
None safety View
None ciclosporin View
None cyclosporine View
None cyclosporine A View
None Sandimmune View
None Sandimmun View
None CicloMulsion View
None NeuroSTAT View